Bone size and density measurements in prepubertal children with Turner syndrome prior to growth hormone therapy

Author： Pitukcheewanont P. Numbenjapon N. Safani D. Rossmiller S. Gilsanz V. Costin G.

ISSN： 0937-941X

Source： Osteoporosis International, Vol.22, Iss.6, 2011-06, pp. : 1709-1715

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Related content

Psoriasis induced by growth hormone therapy in a patient with Turner's syndrome

INTERNATIONAL JOURNAL OF DERMATOLOGY, Vol. 54, Iss. 5, 2015-05 ,pp. : e132-e135

John Wiley & Sons Inc

Access to resources Recommend Favorite

Reduced cortical bone density with normal trabecular bone density in girls with Turner syndrome

By Holroyd C. Davies J. Taylor P. Jameson K. Rivett C. Cooper C. Dennison E.

Osteoporosis International, Vol. 21, Iss. 12, 2010-12 ,pp. : 2093-2099

Springer Publishing Company

Access to resources Recommend Favorite

Therapeutic effects of growth hormone combined with low‐dose stanozolol on growth velocity and final height of girls with Turner syndrome

CLINICAL ENDOCRINOLOGY, Vol. 83, Iss. 2, 2015-08 ,pp. : 223-228

John Wiley & Sons Inc

Access to resources Recommend Favorite

High Degree of Discordance Between Three-Dimensional and Two-Dimensional Lumbar Spine Bone Mineral Density in Turner's Syndrome

By Lage Andrea Z. Brandão Cynthia A. Mendes Judite R. T. Huayllas Martha K. Liberman Bernardo Mendonça Berenice B. Costa Elaine M. F. Verreschi Ieda T. Lazaretti-Castro Marise

Journal of Clinical Densitometry, Vol. 8, Iss. 4, 2005-12 ,pp. : 461-466

Humana Press, Inc

Access to resources Recommend Favorite

Low myocardial glucose uptake in Turner syndrome is unaffected by growth hormone: a randomized, placebo‐controlled FDG‐PET study

CLINICAL ENDOCRINOLOGY, Vol. 83, Iss. 1, 2015-07 ,pp. : 133-140

John Wiley & Sons Inc

Access to resources Recommend Favorite